Pharmsville Balance Sheet Health
Financial Health criteria checks 6/6
Pharmsville has a total shareholder equity of ₩63.9B and total debt of ₩1.6B, which brings its debt-to-equity ratio to 2.6%. Its total assets and total liabilities are ₩71.5B and ₩7.6B respectively. Pharmsville's EBIT is ₩1.0B making its interest coverage ratio -1.6. It has cash and short-term investments of ₩40.1B.
Key information
2.6%
Debt to equity ratio
₩1.64b
Debt
Interest coverage ratio | -1.6x |
Cash | ₩40.13b |
Equity | ₩63.89b |
Total liabilities | ₩7.58b |
Total assets | ₩71.46b |
Recent financial health updates
Pharmsville (KOSDAQ:318010) Has A Pretty Healthy Balance Sheet
Mar 31Here's Why Pharmsville (KOSDAQ:318010) Can Manage Its Debt Responsibly
Dec 24Recent updates
Pharmsville's (KOSDAQ:318010) Sluggish Earnings Might Be Just The Beginning Of Its Problems
Mar 28Pharmsville (KOSDAQ:318010) Has A Pretty Healthy Balance Sheet
Mar 31We're Watching These Trends At Pharmsville (KOSDAQ:318010)
Mar 03Pharmsville's (KOSDAQ:318010) Shareholders Are Down 20% On Their Shares
Feb 10Factors Income Investors Should Consider Before Adding Pharmsville Co., Ltd. (KOSDAQ:318010) To Their Portfolio
Jan 20Here's Why Pharmsville (KOSDAQ:318010) Can Manage Its Debt Responsibly
Dec 24Is Pharmsville Co., Ltd. (KOSDAQ:318010) A High Quality Stock To Own?
Nov 26Financial Position Analysis
Short Term Liabilities: A318010's short term assets (₩44.0B) exceed its short term liabilities (₩5.7B).
Long Term Liabilities: A318010's short term assets (₩44.0B) exceed its long term liabilities (₩1.8B).
Debt to Equity History and Analysis
Debt Level: A318010 has more cash than its total debt.
Reducing Debt: A318010's debt to equity ratio has reduced from 8.9% to 2.6% over the past 5 years.
Debt Coverage: A318010's debt is well covered by operating cash flow (217.3%).
Interest Coverage: A318010 earns more interest than it pays, so coverage of interest payments is not a concern.